This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders as an alternative to the likes of Novo Nordisks semaglutide (Wegovy/Ozempic) and Eli Lillys tirzepatide (Mounjaro/Zepbound).
Compounding pharmacies, which involve the preparation and selling of prescribed medicines are gaining massive popularity across the healthcare sector owing to the rising awareness regarding the benefits of compounded medications.
Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Hims & Hers’ revenue has been soaring on the back of its compounded glucagon-like peptide-1 receptor agonist (GLP-1RA) sales.
AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals. AI-driven screening methods, such as High-Throughput Screening (HTS), allow researchers to rapidly evaluate large libraries of compounds. Can pharma tariffs “Make America Manufacture Again”?
Novo Nordisk is eyeing a cardiometabolic drug market future that is not purely dominated by incretins, after signing a $812m partnership with Deep Apple Therapeutics to access novel compounds for obesity and other diseases. Can pharma tariffs “Make America Manufacture Again”?
A PCR buffer is a mixture of compounds that creates a suitable environment for the polymerase chain reaction. The post PCR Buffer: Polymerase Chain Reaction Mediator appeared first on Pharma Mirror Magazine. You know that DNA making is a life process, and it needs an environment similar to the cell’s internal conditions.
The post Catalent Signs Commercial Supply Agreement with Phathom appeared first on Pharma Mirror Magazine. P-CABs are a new class of medicines that block acid secretion in the stomach.
TAT is a new cancer therapy which combines a substance that emits alpha particles which destroy cancer cells with a compound that selectively accumulates in cancer cells. The combined alpha-emitting agent is administered to a patient to attack cancer cells within the body (Figure 1). It is known to be effective against forms of cancers that.
Ro5’s AI Chemistry Platform also uses advanced machine learning models and cheminformatics tools for quick compound discovery and design from hit identification to lead optimisation. Can pharma tariffs “Make America Manufacture Again”?
These compounds have the potential for addressing a spectrum of neuropsychiatric disorders that currently lack adequate treatment options. Can pharma tariffs “Make America Manufacture Again”?
For nearly 25 years, Jeremy has focused on aiding the biopharmaceutical and health sciences industry in the development of key compounds and new therapies. George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. About the author.
It recently initiated two more Phase III trials of its candidate CagriSema, as well as inking an $812m partnership with Deep Apple Therapeutics to access novel compounds, not GLP-1RAs, for obesity and other diseases. Can pharma tariffs “Make America Manufacture Again”?
This article appears in our free digital magazine Deep Dive: Market Access 2021. Compounding this problem is the fact that the healthcare sector is often glacial in its pace of change, while digital innovations are evolving rapidly every year. The post “A long way to go” for digital health reimbursement appeared first on.
Tariffs and trade disputes are further compounding this challenge, affecting the cost structure of pharma businesses. Can pharma tariffs “Make America Manufacture Again”? The complexity of customs regulations also means lead times for shipping protract, which can have a negative impact on clinical trials and product availability.
This may be compounded by a misconception that the field is mature, with the first discoveries having been made in the 1970s. George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. “It’s not always as obvious a path for STEM students as other disease areas,” says Chaddock. “It’s About the author.
These closures, compounded by the decline of independent pharmacies, create a critical gap in care. These closures put medication access, affordability, and adherence at greater risk. Nearly one in seven Americans already live in a pharmacy desert, and that number continues to climb, particularly in rural and low-income communities.
You may find the help you’re looking for within the pages of this magazine. Special Formulations If you should require help with balancing your oral bacteria, you are then given a personalized and proprietary compound prescription for a medicated mouth rinse. Let’s start here. Have you ever heard of biological dentistry?
Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. They employed hundreds of new salespeople to detail doctors and hospitals, spent millions on TV and magazine ads and handed out masses of free samples. 13 They launched a huge effort to transition PRILOSEC patients their newer product NEXIUM.
Contamination Control: – Handling toxic compounds – Handling infectious compounds – Gowning g. Documentation: – Requirements – Logs – Forms – Rules for corrections d. General Operating Procedures e. General SOPs in the specific areas f.
In March 2025, Novo Nordisk discounted the cost of all doses to $499 per month to competitively price its prized asset against cheaper compounded alternatives. Compounded semaglutide is a personalised weight loss medicine, which is chemically identical to branded alternatives.
The planned 160,000ft² facility will focus on aseptic production and includes areas for material preparation and compounding. June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bird’s-eye view of the current Vetter site in Des Plaines where the clinical manufacturing facility will be built.
The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn.
The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) is poised to grow at a compound annual growth rate of 5.3% Can pharma tariffs “Make America Manufacture Again”? Credit: Vitalii Vodolazskyi via Shutterstock. billion in 2024 to $10.3
CSPC will use its AI-powered drug discovery platform, which uses the technology to analyse the binding patterns of target proteins with existing compound molecules. Can pharma tariffs “Make America Manufacture Again”? The AI models work out targeted optimisation, advancing small molecules with the best developability.
During pharmacy school, I developed a keen interest in unconventional therapies, particularly compounding. While Western medicine was heavily process-oriented and protocol-driven, I was drawn to the innovative and sometimes unorthodox approaches that compounding offered. George Health & Wellness Magazine.
Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 receptor agonists (GLP-1RA), due to the emergence of compounded alternatives in the past few years.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content